Integrated digital error suppression for improved detection of circulating tumor DNA von Newman, Aaron M, Lovejoy, Alexander F, Klass, Daniel M, Kurtz, David M, Chabon, Jacob J, Scherer, Florian, Stehr, Henning, Liu, Chih Long, Bratman, Scott V, Say, Carmen, Zhou, Li, Carter, Justin N, West, Robert B, Sledge Jr, George W, Shrager, Joseph B, Loo, Billy W, Neal, Joel W, Wakelee, Heather A, Diehn, Maximilian, Alizadeh, Ash A

Volltext

Abemaciclib plus fulvestrant in East Asian women with HR+, HER2− advanced breast cancer: Overall survival from MONARCH 2 von Toi, Masakazu, Huang, Chiun‐Sheng, Im, Young‐Hyuck, Sohn, Joohyuk, Zhang, Wei, Sakaguchi, Sachi, Haddad, Nadine, Hal, Gertjan, Sledge, George W.

Volltext

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer von GORDON, M. S, MARGOLIN, K, TALPAZ, M, SLEDGE, G. W, HOLMGREN, E, BENJAMIN, R, STALTER, S, SHAK, S, ADELMAN, D. C

Volltext

Redefining the Target: Chemotherapeutics as Antiangiogenics von MILLER, Kathy D, SWEENEY, Christopher J, SLEDGE, George W

Volltext

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features von GOLDSTEIN, Lori J, GRAY, Robert, SLEDGE, George W, PEREZ, Edith A, SHULMAN, Lawrence N, MARTINO, Silvana, SPARANO, Joseph A, BADVE, Sunil, CHILDS, Barrett H, YOSHIZAWA, Carl, ROWLEY, Steve, SHAK, Steven, BAEHNER, Frederick L, RAVDIN, Peter M, DAVIDSON, Nancy E

Volltext

Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival von Miller, K. D., Weathers, T., Haney, L. G., Timmerman, R., Dickler, M., Shen, J., Sledge Jr, G. W.

Volltext

Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials von Toi, Masakazu, Inoue, Kenichi, Masuda, Norikazu, Iwata, Hiroji, Sohn, Joohyuk, Hae Park, In, Im, Seock‐Ah, Chen, Shin‐Cheh, Enatsu, Sotaro, Turner, P. Kellie, André, Valérie A. M., Hardebeck, Molly C., Sakaguchi, Sachi, Goetz, Matthew P., Sledge, George W.

Volltext

Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology von RECHT, Abram, EDGE, Stephen B, KRAUSE, David A, KUSKE, Robert R, LANGER, Amy S, SLEDGE, George W, WHELAN, Timothy J, PFISTER, David G, SOLIN, Lawrence J, ROBINSON, David S, ESTABROOK, Alison, FINE, Richard E, FLEMING, Gini F, FORMENTI, Silvia, HUDIS, Clifford, KIRSHNER, Jeffrey J

Volltext

Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models von Gökmen-Polar, Yesim, Liu, Yi, Toroni, Rachel A., Sanders, Kerry L., Mehta, Rutika, Badve, Sunil, Rommel, Christian, Sledge, George W.

Volltext

Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer von SCHNEIDER, Bryan P, FENGMIN ZHAO, WOOD, William C, DAVIDSON, Nancy E, SPARANO, Joseph A, MOLIN WANG, STEARNS, Vered, MARTINO, Silvana, JONES, Vicky, PEREZ, Edith A, SAPHNER, Tom, WOLFF, Antonio C, SLEDGE, George W

Volltext

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer von Sparano, Joseph A, Wang, Molin, Martino, Silvana, Jones, Vicky, Perez, Edith A, Saphner, Tom, Wolff, Antonio C, Sledge, George W, Wood, William C, Davidson, Nancy E

Volltext

Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcino... von Solin, Lawrence J., Gray, Robert, Goldstein, Lori J., Recht, Abram, Baehner, Frederick L., Shak, Steven, Badve, Sunil, Perez, Edith A., Shulman, Lawrence N., Martino, Silvana, Davidson, Nancy E., Sledge, George W., Sparano, Joseph A.

Volltext

Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-neg... von Inoue, Kenichi, Masuda, Norikazu, Iwata, Hiroji, Takahashi, Masato, Ito, Yoshinori, Miyoshi, Yasuo, Nakayama, Takahiro, Mukai, Hirofumi, van der Walt, Jan-Stefan, Mori, Joji, Sakaguchi, Sachi, Kawaguchi, Tsutomu, Tanizawa, Yoshinori, Llombart-Cussac, Antonio, Sledge, George W., Toi, Masakazu

Volltext

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103 von Ruddy, Kathryn J., O’Neill, Anne, Miller, Kathy D., Schneider, Bryan P., Baker, Emily, Sparano, Joseph A., Dang, Chau, Northfelt, Donald W., Sledge, George W., Partridge, Ann H.

Volltext

The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antago... von SWEENEY, Christopher J, MILLER, Kathy D, SISSONS, Sean E, NOZAKI, Shinichi, HEILMAN, Douglas K, JIANZHAO SHEN, SLEDGE, George W

Volltext

TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer von Sparano, Joseph A., Goldstein, Lori J., Davidson, Nancy E., Sledge, George W., Gray, Robert

Volltext

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients von Appaiah, Hitesh N, Goswami, Chirayu P, Mina, Lida A, Badve, Sunil, Sledge, Jr, George W, Liu, Yunlong, Nakshatri, Harikrishna

Volltext

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy von Sledge, Jr, George W, Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Inoue, Kenichi, Pivot, Xavier, Burdaeva, Olga, Okera, Meena, Masuda, Norikazu, Kaufman, Peter A, Koh, Han, Grischke, Eva-Maria, Frenzel, Martin, Lin, Yong, Barriga, Susana, Smith, Ian C, Bourayou, Nawel, Llombart-Cussac, Antonio

Volltext

Repression of GADD153/CHOP by NF-κB : a possible cellular defense against endoplasmic reticulum stress-induced cell death von NOZAKI, Shinichi, SLEDGE, George W, NAKSHATRI, Harikrishna

Volltext

Docetaxel Combined With Trastuzumab Is an Active Regimen in HER-2 3+ Overexpressing and Fluorescent In Situ Hybridization–Positive Metastatic Breast Cancer: A Multi-Institutional P... von TEDESCO, K. L, THOR, A. D, EDGERTON, S, SLEDGE, G. W, JOHNSON, D. H, SHYR, Y, BLUM, K. A, GOLDSTEIN, L. J, GRADISHAR, W. J, NICHOLSON, B. P, MERKEL, D. E, MURREY, D

Volltext